BIOMARIN PHARMACEUTICAL INC Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill · last filed 2019-02-28
- BIOMARIN PHARMACEUTICAL INC impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2017-12-31 was $0.00.
- BIOMARIN PHARMACEUTICAL INC impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2017-09-30 was $0.00.
- BIOMARIN PHARMACEUTICAL INC impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC impairment of intangible assets, indefinite-lived (excluding goodwill) for the quarter ending 2016-12-31 was $0.00.
- BIOMARIN PHARMACEUTICAL INC impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2018 was $0.00.
- BIOMARIN PHARMACEUTICAL INC impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- BIOMARIN PHARMACEUTICAL INC impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2016 was $599.12M, a 201.52% increase from fiscal 2015.
- BIOMARIN PHARMACEUTICAL INC impairment of intangible assets, indefinite-lived (excluding goodwill) for fiscal 2015 was $198.70M.
| Period end | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 3 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 3 month as first filed | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 6 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 9 month | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) 12 month |
|---|---|---|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-02-28 | ||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $0.00 derived: sum of 2 quarters · filed 2019-02-28 | $0.00 derived: sum of 3 quarters · filed 2019-02-28 | $0.00 10-K · filed 2019-02-28 | |
| 2017-09-30 | $0.00 10-Q · filed 2017-10-31 | $0.00 derived: sum of 2 quarters · filed 2017-10-31 | $0.00 10-Q · filed 2017-10-31 | ||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-02 | $0.00 10-Q · filed 2017-08-02 | |||
| 2016-12-31 | $0.00 derived: 10-K 6 month − 10-Q 3 month · filed 2017-02-27 | $0.00 10-K · filed 2017-02-27 | $599.12M derived: sum of 3 quarters · filed 2017-10-31 | $599.12M 10-K · filed 2019-02-28 | |
| 2016-09-30 | $0.00 10-Q · filed 2017-10-31 | $599.12M derived: sum of 2 quarters · filed 2017-10-31 | $599.12M 10-Q · filed 2017-10-31 | ||
| 2016-06-30 | $599.12M 10-Q · filed 2017-08-02 | $599.12M 10-Q · filed 2017-08-02 | |||
| 2015-12-31 | $0.00 10-K · filed 2016-02-29 | $0.00 derived: sum of 2 quarters · filed 2016-11-03 | $0.00 derived: sum of 3 quarters · filed 2016-11-03 | $198.70M 10-K · filed 2018-02-26 | |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-03 | $0.00 derived: sum of 2 quarters · filed 2016-11-03 | $0.00 10-Q · filed 2016-11-03 | ||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-08 | $0.00 10-Q · filed 2016-08-08 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-02-27 | ||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $939.00K derived: sum of 3 quarters · filed 2016-02-29 | $939.00K 10-K · filed 2016-02-29 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | $939.00K derived: sum of 2 quarters · filed 2013-10-28 | $939.00K 10-Q · filed 2013-10-28 | $939.00K derived: sum of 4 quarters · filed 2015-03-02 | |
| 2013-06-30 | $939.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29 | $939.00K 10-Q · filed 2013-07-29 | $939.00K derived: sum of 3 quarters · filed 2015-03-02 | $939.00K derived: sum of 4 quarters · filed 2015-03-02 | |
| 2013-03-31 | $0.00 10-Q · filed 2013-04-29 | $0.00 derived: sum of 2 quarters · filed 2015-03-02 | $0.00 derived: sum of 3 quarters · filed 2015-03-02 | $7.00K derived: sum of 4 quarters · filed 2015-03-02 | |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $0.00 derived: sum of 2 quarters · filed 2015-03-02 | $7.00K derived: sum of 3 quarters · filed 2015-03-02 | $6.71M 10-K · filed 2015-03-02 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28 | $7.00K derived: sum of 2 quarters · filed 2013-10-28 | $6.71M 10-Q · filed 2013-10-28 | $6.71M derived: sum of 4 quarters · filed 2015-03-02 | |
| 2012-06-30 | $7.00K derived: 10-Q 6 month − 10-K 3 month · filed 2013-07-29 | $6.71M 10-Q · filed 2013-07-29 | $6.71M derived: sum of 3 quarters · filed 2015-03-02 | $6.71M derived: sum of 4 quarters · filed 2015-03-02 | |
| 2012-03-31 | $6.70M 10-K · filed 2015-03-02 | $6.70M 10-Q · filed 2012-04-30 | $6.70M derived: sum of 2 quarters · filed 2015-03-02 | $6.70M derived: sum of 3 quarters · filed 2015-03-02 | $6.70M derived: sum of 4 quarters · filed 2015-03-02 |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $0.00 derived: sum of 2 quarters · filed 2014-02-26 | $0.00 derived: sum of 3 quarters · filed 2014-02-26 | $0.00 10-K · filed 2014-02-26 | |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-29 | $0.00 derived: sum of 2 quarters · filed 2012-10-29 | $0.00 10-Q · filed 2012-10-29 | ||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $0.00 10-Q · filed 2012-08-02 | |||
| 2011-03-31 | $0.00 10-Q · filed 2012-04-30 | ||||
| 2010-12-31 | $0.00 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |